It's what happens when individuals combine their intelligence, passion, and expertise. When corporations and universities focus on a single goal. When the result is more than any one entity could accomplish on its own.
FibroGen, a biotechnology-based drug discovery company, will maximize synergy with their academic partners as the first major corporation located in the world-class Mission Bay biotechnology center. Flad worked with a developer to fit out 239,000 square feet of a six-story building, located two blocks from the University of California San Francisco Mission Bay teaching and research campus.
The company's new space will feature administrative offices; biology, chemistry, and other specialty labs; and lab support space. Working with colleagues at the university, FibroGen will continue developing drugs to treat fibrosis, anemia, chronic kidney disease, diabetes, and cancer.